Background and aim: We report a case of intravenous drug use associated tricuspid valve endocarditis in a 28-year-old pregnant female at 26-week gestation.
Methods: Patient management required a multidisciplinary collaboration between cardiac surgery, obstetrics and gynecology, and neonatal critical care.
Results: Despite appropriate intravenous antibiotics, the patient developed life-threatening complications and underwent planned cesarean delivery at 28 weeks 6 days gestation followed by interval tricuspid valve replacement 1 week later.
Conclusions: Both the patient and her infant were successfully managed through the perioperative period.
Keywords: valve repair/replacement.
© 2020 Wiley Periodicals LLC.